Project Consultation & Panel Design
Collaborative design of target-specific primers or selection from optimized curated panels for genes, microbial marker regions (e.g., 16S, ITS), or RNA editing sites (e.g., A-to-I loci).
Traditional Sanger sequencing lacks the throughput and sensitivity for analyzing multiple targets or detecting rare variants in complex samples. Amplicon sequencing overcomes this by combining targeted PCR amplification with next-generation sequencing, enabling high-sensitivity, parallel analysis of specific genomic regions with deep coverage. CD BioSciences provides comprehensive amplicon sequencing services, supporting research in oncology, microbiology, genetics, and functional genomics with tailored solutions.
Amplicon sequencing is a highly focused next-generation sequencing (NGS) approach designed for in-depth analysis of user-defined genomic regions. The core methodology involves designing sequence-specific primers to amplify target DNA or cDNA regions through polymerase chain reaction, followed by high-throughput sequencing of these amplified fragments. This targeted strategy achieves exceptionally deep coverage at the loci of interest, making it uniquely powerful for detecting low-frequency genetic variants, profiling microbial communities via marker genes (e.g., 16S/ITS), and quantifying post-transcriptional RNA modifications such as adenosine-to-inosine (A-to-I) editing. It serves as a cost-effective and rapid solution for applications requiring precision and sensitivity beyond broader sequencing methods.
![]()
Fig.1 Demonstration of the workflow for the 16S rRNA and ITS amplicon sequencing. (Athanasopoulou K, et al., 2023)
Amplicon sequencing is engineered for focused genetic interrogation, delivering unparalleled depth and precision at user-specified genomic loci. By concentrating sequencing power on defined targets, this method transforms complex biological questions into manageable, high-resolution data sets. Its design flexibility and analytical sensitivity make it the preferred platform for applications where accuracy, cost-efficiency, and throughput are paramount, including rare variant detection, microbial community profiling, and quantitative RNA modification analysis.
CD BioSciences offers tailored amplicon sequencing services, from custom panel design to advanced data interpretation. Our optimized workflows ensure high specificity and reproducibility for your project, whether focused on somatic variant discovery in cancer, 16S rRNA-based microbiome characterization, or quantitative analysis of RNA adenosine-to-inosine (A-to-I) editing events. We provide the depth and accuracy needed to uncover critical biological insights from diverse sample types.
Our amplicon sequencing service follows an integrated, end-to-end pipeline optimized for accuracy, sensitivity, and scalability. From initial project design to final data interpretation, each step is meticulously controlled to ensure reliable and reproducible results tailored to your specific research objectives, whether targeting genetic variants, microbiome composition, or RNA modifications.
Project Consultation & Panel Design
Collaborative design of target-specific primers or selection from optimized curated panels for genes, microbial marker regions (e.g., 16S, ITS), or RNA editing sites (e.g., A-to-I loci).
Nucleic Acid Extraction & QC
High-quality DNA or RNA extraction using validated protocols, followed by rigorous spectrophotometric and fluorometric quantification, and integrity assessment (e.g., Bioanalyzer, TapeStation) to ensure input suitability.
Target Amplification & Library Preparation
Multiplex PCR amplification of target regions using high-fidelity polymerases, followed by enzymatic cleanup, adapter ligation, and incorporation of dual-index barcodes for efficient sample pooling and multiplexed sequencing.
High-Throughput Sequencing & QC
Pooled libraries are sequenced on Illumina platforms (NovaSeq, MiSeq, or NextSeq) with read lengths and depth optimized for the application, generating high-quality raw data with embedded sample identifiers.
Bioinformatic Analysis & Reporting
Data is processed through specialized pipelines including demultiplexing, primer trimming, read alignment, and application-specific analysis (variant calling, OTU/ASV clustering, or editing efficiency quantification), culminating in a comprehensive report with annotated results and visualizations.
Amplicon sequencing is an ideal technique for high-throughput, highly sensitive quantitative analysis of specific RNA sites, such as A-to-I editing loci. Furthermore, our LC-MS/MS platform offers an orthogonal analytical dimension, enabling global identification and absolute quantification of modified nucleosides, including inosine resulting from A-to-I editing, thereby providing validation and a complementary perspective to sequencing data for more comprehensive and reliable integrated epitranscriptomic analysis. If you are interested in our services, please feel free to contact us for more details and quotation information of related services.
Reference
1. Athanasopoulou K, Adamopoulos P G, Scorilas A. Unveiling the human gastrointestinal tract microbiome: the past, present, and future of metagenomics[J]. Biomedicines, 2023, 11(3): 827.
USA
Quick Links
Easy access to products and services you need from our library via powerful searching tools
Privacy Policy | Cookie Policy
Copyright © 2026 CD BioSciences. All Rights Reserved.